All In Biotech

Free tool

FAERS Monitor: Premarin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020216 or its brand name (Premarin, Estrogens, Conjugated). Reports on generic versions are filed under their own applications.

Reports

59,395

Serious

42,092

71% of reports

Hospitalization

9,554

Death reported

1,858

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • breast cancer9,645
  • breast cancer female8,869
  • drug ineffective3,460
  • nausea2,431
  • headache2,389
  • pain2,320
  • fatigue2,294
  • off label use2,238
  • dizziness1,698
  • breast cancer metastatic1,682
  • dyspnoea1,670
  • malaise1,620
  • diarrhoea1,572
  • arthralgia1,504
  • anxiety1,451

Reports by year received

View as table
YearReports
20044,156
20053,642
20063,215
20071,690
20083,636
20095,174
20109,123
20112,686
20122,586
20132,158
20142,056
20152,473
20162,564
20171,999
20181,802
20192,168
20202,307
20211,531
20221,415
20231,088
2024857
2025644
2026420

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,994,764 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
breast cancer femaleSignal8,869175.4171.21,029,206
breast cancer metastaticSignal1,68265.662.390,254
breast cancerSignal9,64540.840.0336,831
anxiety1,4511.81.7529
headache2,3891.41.3223
pain2,3201.31.3204
malaise1,6201.31.2120
arthralgia1,5041.31.295
dizziness1,6981.21.261
nausea2,4311.11.018
dyspnoea1,6701.01.03
fatigue2,2941.01.04
drug ineffective3,4600.90.920
off label use2,2380.90.923
diarrhoea1,5720.90.836

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.